Jo Van Betsbrugge, Phd
AeroLeads people directory · profile

Jo Van Betsbrugge, Phd Email & Phone Number

President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides at CMC-Rx Consultancy
Location: Greater Montreal Metropolitan Area, Canada 15 work roles 6 schools
1 work email found @bioquadrant.com LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 86%

Contact Signals · 1 work email

Work email j****@bioquadrant.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides
Location
Greater Montreal Metropolitan Area, Canada

Who is Jo Van Betsbrugge, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Jo Van Betsbrugge, Phd is listed as President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides at CMC-Rx Consultancy, based in Greater Montreal Metropolitan Area, Canada. AeroLeads shows a work email signal at bioquadrant.com and a matched LinkedIn profile for Jo Van Betsbrugge, Phd.

Jo Van Betsbrugge, Phd previously worked as President, Full-time Pharmaceutical Development Consultant at Cmc-Rx Consultancy and Senior Consultant Chemistry, Manufacturing & Controls at Kinexum Services Llc. Jo Van Betsbrugge, Phd holds Ph.D from Vrije Universiteit Brussel.

Company email context

Email format at CMC-Rx Consultancy

This section adds company-level context without repeating Jo Van Betsbrugge, Phd's masked contact details.

*@bioquadrant.com
68% confidence

AeroLeads found 1 current-domain work email signal for Jo Van Betsbrugge, Phd. Compare company email patterns before reaching out.

Profile bio

About Jo Van Betsbrugge, Phd

Montreal-area based Drug Development professional, Life Sciences entrepreneur, biopharmaceutical scientist, synthetic organic chemist, co-inventor of Eli Lilly/Amphastar nasal glucagon (BAQSIMI). Specialty: Management of CMC (Chemistry, Manufacturing & Controls), small molecule drugs, peptides, peptide mimetic, intranasal drug delivery, solid oral and injectable dosage forms, synthetic organic chemistry, biotech, drug discovery & development. I cover and manage all areas of CMC development, from pre-clinical development of small molecules and peptides, to formulation development, clinical manufacturing, and scale-up.

Current workplace

Jo Van Betsbrugge, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

CMC-Rx Consultancy
Cmc-Rx Consultancy
President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides
AeroLeads page
15 roles

Jo Van Betsbrugge, Phd work experience

A career timeline built from the work history available for this profile.

President, Full-Time Pharmaceutical Development Consultant

Current

Greater Montreal Metropolitan Area

With 20+ years of hands-on experience in small molecule CMC development, I assist drug developers with the management of the Chemistry, Manufacturing, and Controls aspects of drug development, from pre-clinical development of small molecules and peptides, to formulation development, clinical manufacturing, and scale-up. Clients typically use me as their virtual VP/Director/Project Manager of Manufacturing & Development, whereby I organize, coordinate and execute comprehensive drug development… Show more With 20+ years of hands-on experience in small molecule CMC development, I assist drug developers with the management of the Chemistry, Manufacturing, and Controls aspects of drug development, from pre-clinical development of small molecules and peptides, to formulation development, clinical manufacturing, and scale-up. Clients typically use me as their virtual VP/Director/Project Manager of Manufacturing & Development, whereby I organize, coordinate and execute comprehensive drug development plans on behalf of my clients.I specialize in synthetic organic chemistry, small molecules (chiral and achiral drugs), peptides, peptidomimetics, solid dosage form, and intranasal (powder) delivery. I am trained in organic synthesis, peptide synthesis, cGMP manufacturing, and CMC writing for INDs.Examples of where I typically offer assistance: Pre-IND meeting requests, authoring of CMC sections and documentation for regulatory submission, qualification and management of CDMOs, oversight of cGMP manufacturing activities, establishment of API and drug product specifications, authoring and review of batch records, review of non-conformance reports, analytical method development and validation, control and stability of drug product and drug substance, powder characterization (particle size, hygroscopicity, powder flow properties, thermal behaviour, XRPD, solubility, plume geometry, spray pattern), impurity characterization and synthesis, solid oral dosage forms, tech transfer, CMC gap analysis, risk assessment. Show less

Apr 2019 - Present

Senior Consultant Chemistry, Manufacturing & Controls

Current

Washington Dc-Area

Providing CMC-related assistance to Kinexum's national and international clients: CMC gap analysis, management of drug substance and drug product development programs across multiple therapeutic areas.Co-authoring of Pre-IND meeting requests, and INDs (Module 3).Technical due diligence on late-stage drug development programs.

Sep 2019 - Present

Senior Consultant Chemistry, Manufacturing & Controls

Current

Montreal, Quebec, Canada

Leading Find Therapeutics' drug substance and drug product CMC development program; development and manufacture of clinical drug substance supply, development and manufacture of clinical drug product supply. Authoring of regulatory submissions (Module 3).

Jul 2020 - Present

Senior Consultant Chemistry, Manufacturing & Controls

Current

Management of TIXiMED's drug substance and drug product development and clinical manufacturing programs. Authoring of regulatory submission.

Jul 2021 - Present

Senior Consultant, Chemistry Manufacturing & Controls

Current

London, England, United Kingdom

Leading Kaerus' drug product development and manufacturing program. Authoring of regulatory submission (CMC).

Jun 2023 - Present

Senior Consultant Chemistry, Manufacturing & Controls

Current
Synucure Therapeutics

Greater Montreal Metropolitan Area

Jul 2022 - Present

Senior Consultant, Cmc

Current

Greater Quebec City Metropolitan Area

Maresins Pharma/SPM Therapeutics develops disruptive treatments for detrimental inflammation and pain by harnessing the natural power of maresin compounds.I've been leading the company's drug substance and drug product development activities since July 2019.

Jun 2019 - Present

Senior Consultant, Chemistry, Manufacturing & Controls

Skokie, Illinois, United States

Reporting to the VP Technical Operations and CEO, I provided CMC oversight to one of Levo’s drug substance and drug product development programs. Levo Therapeutics was acquired by Acadia Pharmaceuticals (San Diego) in 2022.

Apr 2019 - May 2022

Member Of The Scientfic Advisory Board

Greater Montreal Metropolitan Area

Member of Ovensa's Scientfic Advisory Board

Nov 2019 - Sep 2020

Innovation Advisor; Ita; Research Council Officer

Montreal, Canada Area

Helping Innovative Firms Grow in Canada through Funding and Advice. Specialty: bio+pharma.Industrial Technology Advisor (biotech/pharma) at the National Research Council's Industrial Research Assistance Program (IRAP). Provided technical and business assessments, strategic advisory services and funding to High Potential Firms. Expert on non-dilutive funding for innovative Canadian companies. Project assessor for Build in Canada Innovation Program and Strategic Innovation… Show more Helping Innovative Firms Grow in Canada through Funding and Advice. Specialty: bio+pharma.Industrial Technology Advisor (biotech/pharma) at the National Research Council's Industrial Research Assistance Program (IRAP). Provided technical and business assessments, strategic advisory services and funding to High Potential Firms. Expert on non-dilutive funding for innovative Canadian companies. Project assessor for Build in Canada Innovation Program and Strategic Innovation Fund.Team Lead Eastern Canada, NRC Concierge Advisory Services Show less

Nov 2013 - Mar 2019

President/Cso/Founder

Laval, Qc, Canada

BioQuadrant Inc: a chemistry-based Contract Development & Manufacturing Organization (CDMO) catering to very specific needs of clients in the biopharma industry. 2006 Graduate CQIB Life Sci incubator, Laval, Canada. As BioQuadrant's CSO, I led the successful execution of 80+ milestone-driven projects in the Life Sciences field.Examples:2009-2013: LY900018/Baqsimi (Locemia Inc/Eli Lilly). NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA; US Patent 20180000904… Show more BioQuadrant Inc: a chemistry-based Contract Development & Manufacturing Organization (CDMO) catering to very specific needs of clients in the biopharma industry. 2006 Graduate CQIB Life Sci incubator, Laval, Canada. As BioQuadrant's CSO, I led the successful execution of 80+ milestone-driven projects in the Life Sciences field.Examples:2009-2013: LY900018/Baqsimi (Locemia Inc/Eli Lilly). NASAL POWDER FORMULATION FOR TREATMENT OF HYPOGLYCEMIA; US Patent 20180000904. https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-severe-hypoglycemia-can-be-administered-without-injection. FDA approval July 2019.2004-2006: ID1101 (Adyvia®), ID1576, ID1135 (Innodia Inc): Scale-up synthesis of hydroxylated amino acids for the treatment of diabetes. Published in US patents 20100048545, 200602238842006-2007: EV-077 (Evolva Inc), targeting diabetic nephropathy; Work published in WO2008089461A12003-2004: R-954 (IPS Pharma); bradykinin antagonist, targeting diabetic peripheral neuropathy; http://www.ncbi.nlm.nih.gov/pubmed/24361511 2010-2013: UCM765 (Cosmas Therapeutics): Melatonin receptor ligands 2008: NVT-0275 (NorVison Inc); mono-trisubstitued trisulfonated porphyrazine for photodynamic therapy of cancer; 2008: Theratechnologies; Tesamorelin - work on impurities2006: BA-1049 (BioAxone); Rho kinase inhibitor; potential treatment of cerebral vascular disorders and degenerative eye disease; http://bioaxonebio.com/technology-overview/pipeline/2005: Elamipretide (Bendavia, SS-31, D-Arg-dimethylTyr-Lys-Phe-NH2), http://biotechnologyfocus.ca/an-ircm-breakthrough-leads-to-a-potential-drug-for-a-rare-disease/ 2003-2005: PL-100/PPL100/Mk8122/TMB-607 (Ambrilia/TaiMed Biologics); second generation HIV Protease inhibitor; Performed chemical synthesis route optimization and scale-up; http://www.taimedbiologics.com/pipeline/352000-2001: CCI1004 (ConjuChem Inc); long acting thrombin inhibitor; Show less

Oct 1999 - Mar 2017

Consultant, Vice-President, Chemistry & Manufacturing

Insymbiosis Discovery Inc

Montreal, Canada Area

Key tasks: strategic scientific planning (budgets, protocol development,...) of Insymbiosis' pre-clinical chemistry programs; project management of all chemistry-related projects; preparation of R&D proposals for international clients; analogue syntheses and scale-up of experimental drugs; consultation on CMC-related issues; development of a comprehensive pre-clinical and clinical chemical/analytical development plan for a small molecule therapeutic to treat renal disease.

Nov 2005 - Mar 2008

Consultant, Manufacturing Project Manager

Development and scale-up of a novel synthesis route for a thrombin inhibitor.

Jan 2001 - Jun 2001

Post Doctoral Fellow

Solid-supported synthesis of azasugar peptide mimetics. Laboratory for Organic Chemistry; Director: Prof. Dr. William D. Lubell

Sep 1997 - May 2000
6 education records

Jo Van Betsbrugge, Phd education

(2 X 3-Month Internship)

Montreal Clinical Research Institute (Ircm)

Professional Training Course

The Center For Professional Innovation & Education Inc
FAQ

Frequently asked questions about Jo Van Betsbrugge, Phd

Quick answers generated from the profile data available on this page.

What company does Jo Van Betsbrugge, Phd work for?

Jo Van Betsbrugge, Phd works for CMC-Rx Consultancy.

What is Jo Van Betsbrugge, Phd's role at CMC-Rx Consultancy?

Jo Van Betsbrugge, Phd is listed as President CMC-Rx Consultancy | Drug Development Leader - Small Molecules & Peptides at CMC-Rx Consultancy.

What is Jo Van Betsbrugge, Phd's email address?

AeroLeads has found 1 work email signal at @bioquadrant.com for Jo Van Betsbrugge, Phd at CMC-Rx Consultancy.

Where is Jo Van Betsbrugge, Phd based?

Jo Van Betsbrugge, Phd is based in Greater Montreal Metropolitan Area, Canada while working with CMC-Rx Consultancy.

What companies has Jo Van Betsbrugge, Phd worked for?

Jo Van Betsbrugge, Phd has worked for Cmc-Rx Consultancy, Kinexum Services Llc, Find Therapeutics, Tiximed, and Kaerus Bioscience Ltd..

How can I contact Jo Van Betsbrugge, Phd?

You can use AeroLeads to view verified contact signals for Jo Van Betsbrugge, Phd at CMC-Rx Consultancy, including work email, phone, and LinkedIn data when available.

What schools did Jo Van Betsbrugge, Phd attend?

Jo Van Betsbrugge, Phd holds Ph.D from Vrije Universiteit Brussel.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.